Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane
Brief Report
Published: 02 January 2024
The Journal of Membrane Biology
Nahit Rizaner, Scott P. Fraser, Ilknur Bugan Gul, Esma Purut, Mustafa B. A. Djamgoz & Seyhan Altun
Abstract
There is increasing evidence, mostly from breast cancer, that use of local anaesthetics during surgery can inhibit disease recurrence by suppressing the motility of the cancer cells dependent on inherent voltage-gated sodium channels (VGSCs). Here, the possibility that lidocaine could affect cellular behaviours associated with metastasis was tested using the Dunning cell model of rat prostate cancer. Mostly, the strongly metastatic (VGSC-expressing) Mat-LyLu cells were used under both normoxic and hypoxic conditions. The weakly metastatic AT-2 cells served for comparison in some experiments. Lidocaine (1–500 μM) had no effect on cell viability or growth but suppressed Matrigel invasion dose dependently in both normoxia and hypoxia. Used as a control, tetrodotoxin produced similar effects. Exposure to hypoxia increased Nav1.7 mRNA expression but VGSCα protein level in plasma membrane was reduced. Lidocaine under both normoxia and hypoxia had no effect on Nav1.7 mRNA expression. VGSCα protein expression was suppressed by lidocaine under normoxia but no effect was seen in hypoxia. It is concluded that lidocaine can suppress prostate cancer invasiveness without effecting cellular growth or viability. Extended to the clinic, the results would suggest that use of lidocaine, and possibly other local anaesthetics, during surgery can suppress any tendency for post-operative progression of prostate cancer.
SOME OTHER LIDOCAINE CANCER STUDIES
Li R, Xiao C, Liu H, Huang Y, Dilger JP, Lin J (2018) Effects of local anaesthetics on breast cancer cell viability and migration. BMC Cancer 18(1):666. doi.org/10.1186/s12885-018-...
Liu T, Jiang F, Yu LY, Wu YY (2022) Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation. Bioengineered 13(3):6359–6370. doi.org/10.1080/21655979.20...
Soto G, Calero F, Naranjo M (2020) Lidocaína em cirurgia oncológica: o papel do bloqueio dos canais de sódio dependentes de voltagem. Revisão narrativa [Lidocaine in oncological surgery: the role of blocking in voltage-gated sodium channels. A narrative review]. Braz J Anesthesiol 70(5):527–533. doi.org/10.1016/j.bjan.2020...
Sun M, Huang S, Gao Y (2021) Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/β-catenin pathway. Transl Cancer Res 10(7):3479–3490. doi.org/10.21037/tcr-21-1047
Xing B, Yang L, Cui Y (2022) Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation. Cancer Biomark 33(3):317–330. doi.org/10.3233/CBM-210249